You're reading a SIGNA Wire case file. Get alerts like this for free. Sign in · Learn more →
ANI Pharmaceuticals, Inc.FDAMed source confidence · 80%Jun 22, 2026, 10:00 AM UTC · 16d ago

ANI Pharmaceuticals, Inc. — FDA Class II (D-0543-2026)

Case File

ANI Pharmaceuticals, Inc. is recalling 3,964 cartons of a human prescription drug due to defective containers. This recall is classified as a safety issue. The affected products have NDC numbers ranging from 70954-530 to 70954-534.

Sign in to follow ANI Pharmaceuticals, Inc. and get alerts like this
Key Points
  • ANI Pharmaceuticals is recalling 3,964 cartons of a human prescription drug.
  • The recall is due to defective containers.
  • Affected NDC numbers range from 70954-530 to 70954-534.
  • Consumers should check their medicine cabinets for these products.
Why This Matters

Patients using these drugs should check for the recalled cartons, as they may be compromised. The recall affects 3,964 cartons of human prescription drugs.

View original filing →
Sign in to follow ANI Pharmaceuticals, Inc. and get alerts like this

SIGNA Wire provides informational summaries of official government filings. Not investment advice.